Vcanbio Cell & Gene Engineering Corp., Ltd

SSE:600645.SS

23.39 (CNY) • At close June 6, 2025
Overview | Financials

Numbers are in millions (except for per share data and ratios) CNY.

20242023202220212020201920182017201620152014201320122011201020092008200720062005200420032002200120001999199819971996199519941993
Revenue 1,585.4231,589.7231,554.8871,535.3291,318.8941,386.7791,320.518870.913837.901708.995476.865361.31300.343246.738268.473307.749288.105392.188407.355354.367281.256325.034311.306296.054200.937100.044186.281298.374254.939146.594175.885122.086
Cost of Revenue 487.743491.376503.008466.982441.486448.712442.293262.698294.932245.347126.138107.79578.33650.94869.558116.125119.195218.932272.63239.715204.511279.604271.409262.624181.48787.02144.915216.381197.915116.324098.181
Gross Profit 1,097.6811,098.3471,051.8791,068.347877.408938.067878.225608.215542.969463.648350.726253.515222.007195.789198.915191.624168.91173.257134.725114.65276.74545.4339.89733.4319.44913.02441.36681.99357.02330.27175.88523.905
Gross Profit Ratio 0.6920.6910.6760.6960.6650.6760.6650.6980.6480.6540.7350.7020.7390.7940.7410.6230.5860.4420.3310.3240.2730.140.1280.1130.0970.130.2220.2750.2240.20610.196
Reseach & Development Expenses 182.105184.488147.31135.313114.431109.649103.29665.33145.99243.59530.44923.40718.397011.40400000000000000000
General & Administrative Expenses 267.496100.17496.414265.0888.592.45111.266122.095115.35392.41687.51359.82351.88469.69219.14986.56577.27361.84776.25396.06698.14127.66768.02825.80714.01515.94819.40319.1978.81611.12905.52
Selling & Marketing Expenses 346.119373.919392.608407.844310.329308.523315.824215.755154.829124.51698.24384.11773.10869.06371.84869.82949.54153.87238.70139.20930.39720.61114.95910.7136.8863.9947.26911.2310.9442.3500.651
SG&A 613.615474.093489.022672.924398.829400.973427.09337.85270.182216.932185.756143.939124.992138.75690.997156.394126.814115.719114.953135.274128.53848.27882.98736.5220.90119.94326.67330.42719.7613.47906.171
Other Expenses 166.169318.111245.68268.744241.667227.5762.3826.15312.68610.7196.50718.99410.1833.433-2.851-14.5348.443-13.10116.433-89.7450.231.156-2.8481.812.23828.1990.9280.2053.7961.8190.136-0.34
Operating Expenses 961.89967.223882.014876.981754.927738.198767.612532.144424.41354.452298.427248.999207.479152.942151.746170.429139.022126.841123.367141.978133.03750.46484.45337.69621.34620.55828.22935.05424.00814.6570.1369.528
Operating Income 135.791131.125156.007219.793175.895180.866102.16418.16380.524252.37856.843.53928.4155.03841.55122.09324.86445.2323.312-51.841-62.6218.339-52.28111.23854.9439.7228.01138.37827.94623.17834.89922.116
Operating Income Ratio 0.0860.0820.10.1430.1330.130.0770.0210.0960.3560.1190.010.0950.2230.1550.0720.0860.1150.008-0.146-0.2230.026-0.1680.0380.2730.0970.150.1290.110.1580.1980.181
Total Other Income Expenses Net 0.1551.462-0.7993.165-264.9874.5662.382-29.40512.5139.886.28918.969.5613.394-2.851-14.93643.419-14.28415.985-102.065-10.4230.039-5.909-0.86-34.12425.8445.472-3.9711.9960.2550.136-0.387
Income Before Tax 135.946132.586155.207222.957-89.093113.475104.54624.31693.037262.25863.12922.49937.97258.43338.77.15773.30732.13119.733-127.515-64.5538.379-56.91210.37855.19731.98928.37837.91729.94223.43335.03521.73
Income Before Tax Ratio 0.0860.0830.10.145-0.0680.0820.0790.0280.1110.370.1320.0620.1260.2370.1440.0230.2540.0820.048-0.36-0.230.026-0.1830.0350.2750.320.1520.1270.1170.160.1990.178
Income Tax Expense 46.59234.03548.52571.74737.82959.5238.69334.71542.95345.21916.2545.59711.20911.28611.1048.7568.43111.9188.9346.2293.6092.1143.1036.4196.8156.424.6577.7634.3292.2763.2191.583
Net Income 100.352106.453112.987155.32-126.92249.69559.253-18.4637.86208.35335.4657.21613.89923.4268.382.12539.09811.8757.976-142.299-77.2813.143-62.5112.52647.39925.68724.40132.11325.61321.15731.37320.146
Net Income Ratio 0.0630.0670.0730.101-0.0960.0360.045-0.0210.0450.2940.0740.020.0460.0950.0310.0070.1360.030.02-0.402-0.2750.01-0.2010.0090.2360.2570.1310.1080.10.1440.1780.165
EPS 0.220.230.240.33-0.270.110.15-0.0530.10.540.10.020.040.070.0260.0070.120.0370.031-0.57-0.310.007-0.250.0060.0430.0470.0460.0840.0740.0610.110.07
EPS Diluted 0.220.230.240.33-0.270.110.15-0.0530.10.540.10.020.040.070.0260.0070.120.0370.031-0.57-0.310.007-0.250.0060.0430.0470.0460.0840.0740.0610.110.07
EBITDA 278.512277.107321.197358.7353.782277.119261.933192.652157.107332.40197.20668.96779.53485.27370.62741.501102.54160.38646.38329.616-43.56223.478-41.74225.22865.7484.48721.97343.42633.01515.614175.88514.377
EBITDA Ratio 0.1760.1740.2070.2340.0410.20.1980.2210.1880.4690.2040.1910.2650.3460.2630.1350.3560.1540.1140.084-0.1550.072-0.1340.0850.3270.0450.1180.1460.130.10710.118